APO Research

APO RESEARCH · REPORT

Enteric Parasite Testing

Selected research

Market Analysis & Forecast

Global Enteric Parasite Testing Market Analysis and Forecast 2026-2032

Market perspective

The global Enteric Parasite Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Enteric Parasite Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enteric Parasite Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enteric Parasite Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enteric Parasite Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Enteric Parasite Testing include Abbott Laboratories, Diasorin, Biomérieux, Qiagen, Meridian Bioscience, Bio-Rad Laboratories and Thermo Fisher Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Enteric Parasite Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enteric Parasite Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Enteric Parasite Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enteric Parasite Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enteric Parasite Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Enteric Parasite Testing revenue, projected growth trends, production technology, application and end-user industry.

Enteric Parasite Testing Segment by Company

Abbott Laboratories

Diasorin

Biomérieux

Qiagen

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Enteric Parasite Testing Segment by Type

Microscopy

Enzyme Immunoassays

Molecular Diagnostics

Serological Tests

Enteric Parasite Testing Segment by Application

Research Institution

Hospital

Clinic

Enteric Parasite Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric Parasite Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enteric Parasite Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric Parasite Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Enteric Parasite Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Enteric Parasite Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enteric Parasite Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enteric Parasite Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microscopy Major Player Table 3. Enzyme Immunoassays Major Player Table 4. Molecular Diagnostics Major Player Table 5. Serological Tests Major Player Table 6. Global Enteric Parasite Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Research Institution Major Player Table 8. Hospital Major Player Table 9. Clinic Major Player Table 10. Enteric Parasite Testing Industry Trends Table 11. Enteric Parasite Testing Industry Drivers Table 12. Enteric Parasite Testing Industry Opportunities and Challenges Table 13. Enteric Parasite Testing Industry Restraints Table 14. Global Enteric Parasite Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Enteric Parasite Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Enteric Parasite Testing Market Share by Region (2021-2026) Table 17. Global Enteric Parasite Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Enteric Parasite Testing Market Share by Region (2027-2032) Table 19. Global Enteric Parasite Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Enteric Parasite Testing Revenue Market Share by Players (2021-2026) Table 21. Global Enteric Parasite Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Enteric Parasite Testing Key Players Headquarters & Area Served Table 23. Global Enteric Parasite Testing Players, Product Type & Application Table 24. Global Enteric Parasite Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Enteric Parasite Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Enteric Parasite Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Enteric Parasite Testing Revenue Market Share by Type (2021-2026) Table 31. Global Enteric Parasite Testing Revenue Market Share by Type (2027-2032) Table 32. Global Enteric Parasite Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Enteric Parasite Testing Revenue Market Share by Application (2021-2026) Table 36. Global Enteric Parasite Testing Revenue Market Share by Application (2027-2032) Table 37. Abbott Laboratories Company Information Table 38. Abbott Laboratories Business Overview Table 39. Abbott Laboratories Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott Laboratories Enteric Parasite Testing Product Portfolio Table 41. Abbott Laboratories Recent Development Table 42. Diasorin Company Information Table 43. Diasorin Business Overview Table 44. Diasorin Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Diasorin Enteric Parasite Testing Product Portfolio Table 46. Diasorin Recent Development Table 47. Biomérieux Company Information Table 48. Biomérieux Business Overview Table 49. Biomérieux Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Biomérieux Enteric Parasite Testing Product Portfolio Table 51. Biomérieux Recent Development Table 52. Qiagen Company Information Table 53. Qiagen Business Overview Table 54. Qiagen Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Qiagen Enteric Parasite Testing Product Portfolio Table 56. Qiagen Recent Development Table 57. Meridian Bioscience Company Information Table 58. Meridian Bioscience Business Overview Table 59. Meridian Bioscience Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Meridian Bioscience Enteric Parasite Testing Product Portfolio Table 61. Meridian Bioscience Recent Development Table 62. Bio-Rad Laboratories Company Information Table 63. Bio-Rad Laboratories Business Overview Table 64. Bio-Rad Laboratories Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio-Rad Laboratories Enteric Parasite Testing Product Portfolio Table 66. Bio-Rad Laboratories Recent Development Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Enteric Parasite Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Thermo Fisher Scientific Enteric Parasite Testing Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. North America Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Enteric Parasite Testing Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Enteric Parasite Testing Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Enteric Parasite Testing Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Enteric Parasite Testing Revenue by Country (US$ Million) & (2027-2032) Table 86. China Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 87. China Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 88. China Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 89. China Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Enteric Parasite Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Enteric Parasite Testing Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Enteric Parasite Testing Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Enteric Parasite Testing Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Enteric Parasite Testing Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Enteric Parasite Testing Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Enteric Parasite Testing Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Enteric Parasite Testing Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Enteric Parasite Testing Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Enteric Parasite Testing Image Figure 2. Global Enteric Parasite Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enteric Parasite Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microscopy Image Figure 5. Enzyme Immunoassays Image Figure 6. Molecular Diagnostics Image Figure 7. Serological Tests Image Figure 8. Global Enteric Parasite Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Enteric Parasite Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Research Institution Image Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Global Enteric Parasite Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Enteric Parasite Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Enteric Parasite Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Enteric Parasite Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Enteric Parasite Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Enteric Parasite Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Enteric Parasite Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Enteric Parasite Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Enteric Parasite Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Enteric Parasite Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Enteric Parasite Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Enteric Parasite Testing Revenue Share by Type (2021-2032) Figure 26. North America Enteric Parasite Testing Revenue Share by Application (2021-2032) Figure 27. North America Enteric Parasite Testing Revenue Share by Country (2021-2032) Figure 28. United States Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Enteric Parasite Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Enteric Parasite Testing Revenue Share by Type (2021-2032) Figure 33. Europe Enteric Parasite Testing Revenue Share by Application (2021-2032) Figure 34. Europe Enteric Parasite Testing Revenue Share by Country (2021-2032) Figure 35. Germany Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Enteric Parasite Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Enteric Parasite Testing Revenue Share by Type (2021-2032) Figure 45. China Enteric Parasite Testing Revenue Share by Application (2021-2032) Figure 46. Asia Enteric Parasite Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Enteric Parasite Testing Revenue Share by Type (2021-2032) Figure 48. Asia Enteric Parasite Testing Revenue Share by Application (2021-2032) Figure 49. Asia Enteric Parasite Testing Revenue Share by Region (2021-2032) Figure 50. Japan Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Enteric Parasite Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Enteric Parasite Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Enteric Parasite Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Enteric Parasite Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Enteric Parasite Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Microscopy
  • Enzyme Immunoassays
  • Molecular Diagnostics
  • Serological Tests
Applications
  • Research Institution
  • Hospital
  • Clinic
Companies covered
  • Abbott Laboratories
  • Diasorin
  • Biomérieux
  • Qiagen
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enteric Parasite Testing Market by Type
  3. 1.2.1 Global Enteric Parasite Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microscopy
  5. 1.2.3 Enzyme Immunoassays
  6. 1.2.4 Molecular Diagnostics
  7. 1.2.5 Serological Tests
  8. 1.3 Enteric Parasite Testing Market by Application
  9. 1.3.1 Global Enteric Parasite Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institution
  11. 1.3.3 Hospital
  12. 1.3.4 Clinic
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Enteric Parasite Testing Market Dynamics
  1. 2.1 Enteric Parasite Testing Industry Trends
  2. 2.2 Enteric Parasite Testing Industry Drivers
  3. 2.3 Enteric Parasite Testing Industry Opportunities and Challenges
  4. 2.4 Enteric Parasite Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Enteric Parasite Testing Market Perspective (2021-2032)
  2. 3.2 Global Enteric Parasite Testing Growth Trends by Region
  3. 3.2.1 Global Enteric Parasite Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enteric Parasite Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Enteric Parasite Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Enteric Parasite Testing Revenue by Players
  2. 4.1.1 Global Enteric Parasite Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Enteric Parasite Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Enteric Parasite Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enteric Parasite Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Enteric Parasite Testing Key Players Headquarters & Area Served
  7. 4.4 Global Enteric Parasite Testing Players, Product Type & Application
  8. 4.5 Global Enteric Parasite Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Enteric Parasite Testing Market CR5 and HHI
  11. 4.6.3 2025 Enteric Parasite Testing Tier 1, Tier 2, and Tier 3
5 Enteric Parasite Testing Market Size by Type
  1. 5.1 Global Enteric Parasite Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 5.3 Global Enteric Parasite Testing Revenue Market Share by Type (2021-2032)
6 Enteric Parasite Testing Market Size by Application
  1. 6.1 Global Enteric Parasite Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Enteric Parasite Testing Revenue by Application (2021-2032)
  3. 6.3 Global Enteric Parasite Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Enteric Parasite Testing Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Diasorin
  8. 7.2.1 Diasorin Company Information
  9. 7.2.2 Diasorin Business Overview
  10. 7.2.3 Diasorin Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Diasorin Enteric Parasite Testing Product Portfolio
  12. 7.2.5 Diasorin Recent Developments
  13. 7.3 Biomérieux
  14. 7.3.1 Biomérieux Company Information
  15. 7.3.2 Biomérieux Business Overview
  16. 7.3.3 Biomérieux Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Biomérieux Enteric Parasite Testing Product Portfolio
  18. 7.3.5 Biomérieux Recent Developments
  19. 7.4 Qiagen
  20. 7.4.1 Qiagen Company Information
  21. 7.4.2 Qiagen Business Overview
  22. 7.4.3 Qiagen Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Qiagen Enteric Parasite Testing Product Portfolio
  24. 7.4.5 Qiagen Recent Developments
  25. 7.5 Meridian Bioscience
  26. 7.5.1 Meridian Bioscience Company Information
  27. 7.5.2 Meridian Bioscience Business Overview
  28. 7.5.3 Meridian Bioscience Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Meridian Bioscience Enteric Parasite Testing Product Portfolio
  30. 7.5.5 Meridian Bioscience Recent Developments
  31. 7.6 Bio-Rad Laboratories
  32. 7.6.1 Bio-Rad Laboratories Company Information
  33. 7.6.2 Bio-Rad Laboratories Business Overview
  34. 7.6.3 Bio-Rad Laboratories Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Rad Laboratories Enteric Parasite Testing Product Portfolio
  36. 7.6.5 Bio-Rad Laboratories Recent Developments
  37. 7.7 Thermo Fisher Scientific
  38. 7.7.1 Thermo Fisher Scientific Company Information
  39. 7.7.2 Thermo Fisher Scientific Business Overview
  40. 7.7.3 Thermo Fisher Scientific Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Scientific Enteric Parasite Testing Product Portfolio
  42. 7.7.5 Thermo Fisher Scientific Recent Developments
8 North America
  1. 8.1 North America Enteric Parasite Testing Revenue (2021-2032)
  2. 8.2 North America Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Enteric Parasite Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Enteric Parasite Testing Revenue by Type (2027-2032)
  5. 8.3 North America Enteric Parasite Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Enteric Parasite Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Enteric Parasite Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Enteric Parasite Testing Revenue by Application (2027-2032)
  9. 8.5 North America Enteric Parasite Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Enteric Parasite Testing Revenue by Country
  11. 8.6.1 North America Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Enteric Parasite Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Enteric Parasite Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Enteric Parasite Testing Revenue (2021-2032)
  2. 9.2 Europe Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Enteric Parasite Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Enteric Parasite Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Enteric Parasite Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Enteric Parasite Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Enteric Parasite Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Enteric Parasite Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Enteric Parasite Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Enteric Parasite Testing Revenue by Country
  11. 9.6.1 Europe Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Enteric Parasite Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Enteric Parasite Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Enteric Parasite Testing Revenue (2021-2032)
  2. 10.2 China Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Enteric Parasite Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Enteric Parasite Testing Revenue by Type (2027-2032)
  5. 10.3 China Enteric Parasite Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Enteric Parasite Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Enteric Parasite Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Enteric Parasite Testing Revenue by Application (2027-2032)
  9. 10.5 China Enteric Parasite Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enteric Parasite Testing Revenue (2021-2032)
  2. 11.2 Asia Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Enteric Parasite Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Enteric Parasite Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Enteric Parasite Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Enteric Parasite Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Enteric Parasite Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Enteric Parasite Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Enteric Parasite Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Enteric Parasite Testing Revenue by Country
  11. 11.6.1 Asia Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Enteric Parasite Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Enteric Parasite Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enteric Parasite Testing Revenue (2021-2032)
  2. 12.2 SAMEA Enteric Parasite Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Enteric Parasite Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Enteric Parasite Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Enteric Parasite Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Enteric Parasite Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Enteric Parasite Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Enteric Parasite Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Enteric Parasite Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Enteric Parasite Testing Revenue by Country
  11. 12.6.1 SAMEA Enteric Parasite Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Enteric Parasite Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Enteric Parasite Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research